Nanalysis Scientific (CVE:NSCI) Trading Down 7.7% – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCI) fell 7.7% during mid-day trading on Monday . The company traded as low as C$0.12 and last traded at C$0.12. 133,400 shares were traded during trading, an increase of 163% from the average session volume of 50,686 shares. The stock had previously closed at C$0.13.

Nanalysis Scientific Price Performance

The company’s 50 day simple moving average is C$0.15 and its 200 day simple moving average is C$0.17. The company has a current ratio of 1.42, a quick ratio of 1.11 and a debt-to-equity ratio of 71.72. The stock has a market capitalization of C$13.78 million, a PE ratio of -1.20 and a beta of -0.75.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.